1. Home
  2. GPMT vs ESLA Comparison

GPMT vs ESLA Comparison

Compare GPMT & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Point Mortgage Trust Inc.

GPMT

Granite Point Mortgage Trust Inc.

HOLD

Current Price

$1.51

Market Cap

75.2M

Sector

Real Estate

ML Signal

HOLD

Logo Estrella Immunopharma Inc.

ESLA

Estrella Immunopharma Inc.

HOLD

Current Price

$1.27

Market Cap

69.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPMT
ESLA
Founded
2015
2021
Country
United States
United States
Employees
28
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.2M
69.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GPMT
ESLA
Price
$1.51
$1.27
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.00
$8.00
AVG Volume (30 Days)
119.7K
44.8K
Earning Date
05-05-2026
05-26-2026
Dividend Yield
12.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$458.85
N/A
Revenue Next Year
$8.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.24
$0.78
52 Week High
$3.12
$3.15

Technical Indicators

Market Signals
Indicator
GPMT
ESLA
Relative Strength Index (RSI) 50.65 38.45
Support Level $1.24 $0.96
Resistance Level $1.66 $1.35
Average True Range (ATR) 0.08 0.15
MACD 0.01 -0.07
Stochastic Oscillator 54.01 3.31

Price Performance

Historical Comparison
GPMT
ESLA

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Share on Social Networks: